TENX
Tenax TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
TENX Profile
Tenax Therapeutics, Inc.
A specialty pharmaceutical company that focused on products that address cardiovascular and pulmonary diseases
101 Glen Lennox Drive, Suite 300, Chapel Hill, North Carolina 27517
--
Tenax Therapeutics, Inc., originally incorporated as a New Jersey corporation in 1967 under the name Rudmer, David & Associates, Inc., was subsequently renamed Synthetic Blood International, Inc. Effective June 30, 2008, the Company changed its registered seat to Delaware and changed its name to Oxygen Biotherapeutics, Inc. On September 19, 2014, the company changed its name to Tenax Therapeutics, Inc. The Company is a specialty pharmaceutical company focused on identifying, developing and commercializing products to address cardiovascular and pulmonary diseases with unmet medical needs. The company's primary business objective is to identify, develop and commercialize novel therapeutic products for disease indications in important areas representing clinical needs and business opportunities.
